about
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating DisorderPharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lisdexamfetamine: A pharmacokinetic review.
@en
type
label
Lisdexamfetamine: A pharmacokinetic review.
@en
prefLabel
Lisdexamfetamine: A pharmacokinetic review.
@en
P2093
P1476
Lisdexamfetamine: A pharmacokinetic review.
@en
P2093
Eloisa Comiran
Pedro Eduardo Fröehlich
Renata Pereira Limberger
P304
P356
10.1016/J.EJPS.2016.04.026
P407
P577
2016-04-25T00:00:00Z